| Breakdown | TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 53.25B | 62.01B | 23.61B | 21.31B | 20.78B | 19.86B |
| Gross Profit | 28.73B | 26.67B | 23.52B | 21.29B | 20.80B | 19.80B |
| EBITDA | 13.35B | 12.12B | 10.34B | 8.05B | 8.73B | 9.01B |
| Net Income | 9.82B | 8.43B | 7.12B | 5.00B | 6.22B | 6.43B |
Balance Sheet | ||||||
| Total Assets | 1.16T | 1.12T | 1.04T | 975.72B | 943.60B | 837.68B |
| Cash, Cash Equivalents and Short-Term Investments | 16.79B | 92.81B | 93.25B | 80.52B | 92.72B | 88.15B |
| Total Debt | 181.44B | 355.82B | 208.49B | 194.50B | 187.45B | 164.17B |
| Total Liabilities | 1.09T | 1.05T | 982.98B | 922.51B | 893.22B | 791.85B |
| Stockholders Equity | 65.68B | 64.13B | 58.73B | 52.98B | 50.18B | 45.65B |
Cash Flow | ||||||
| Free Cash Flow | 14.40B | 12.73B | 10.00B | 11.14B | 21.61B | -4.17B |
| Operating Cash Flow | 15.63B | 13.84B | 11.09B | 12.15B | 22.71B | -3.33B |
| Investing Cash Flow | -5.11B | -5.78B | -20.75B | -20.76B | -24.39B | -3.51B |
| Financing Cash Flow | -7.73B | -4.31B | -2.61B | -2.16B | -1.61B | -1.95B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | C$159.27B | 16.58 | 11.25% | 3.61% | -4.35% | 21.22% | |
72 Outperform | C$371.23B | 17.05 | 15.95% | 2.58% | 1.99% | 22.50% | |
71 Outperform | C$77.45B | 17.05 | 13.77% | 2.64% | 6.36% | 7.80% | |
70 Outperform | C$138.32B | 14.16 | 15.24% | 3.07% | -3.32% | 27.25% | |
68 Neutral | C$137.30B | 14.57 | 11.06% | 4.32% | -5.52% | 47.19% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | C$263.97B | 17.60 | 11.85% | 3.34% | -11.69% | -11.99% |